Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Tuberous Sclerosis × Cannabidiol × Clear all

Status

Active not recruiting 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Tuberous Sclerosis 1 Seizures 1 Marijuana Abuse 1 Lennox Gastaut Syndrome 1 Epilepsies, Myoclonic 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Sirolimus 3 radiprodil 1 exemestane 1 Vigabatrin 1 Solutions 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Phlebotomy 1 Injections 1 Genetic Testing 1 Fluid Therapy 1 Everolimus 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05485831 2026-02-17

EpiTALY

Jazz Pharmaceuticals

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡